Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new study led by UCL Institute of Neurology, published today in Brain.
Publication date: 15 November 2017
This year's annual address, held on 7th November 2017, began with a review of the year's successes presented by Professor Michael Hanna, Director of UCL Institute of Neurology.
Publication date: 10 November 2017
Professor Sarah Tabrizi, director of the UCL Huntington’s Disease Centre at the UCL Institute of Neurology, has received the 2017 International Leslie Gehry Brenner prize for Innovation in Science.
Publication date: 9 November 2017